Sign in
4

Changes in Ownership

X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-005382

Options or other derivatives

  • President and CEO acquired 1,189,578 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ragan Paula President and CEO 2024-02-13 Grant or award · Stock Appreciation Right +1,189,578 1,189,578 D
Loading xslF345X05/wk-form4_1708121356.xml…